8-K: Aehr Test Systems Reports Mixed Q1 Results but Reaffirms Full-Year Guidance

Sentiment:

Quarterly Report


Aehr Test Systems announced its fiscal 2025 first quarter results, showing a decrease in revenue and net income compared to the previous year, but reaffirmed its full-year guidance.

Worse than expectedThe company's revenue and net income were significantly lower than the same quarter of the previous year.

Summary

  • Aehr Test Systems reported a first quarter fiscal 2025 revenue of $13.1 million, down from $20.6 million in the same quarter last year.
  • GAAP net income for the quarter was $0.7 million, or $0.02 per diluted share, a decrease from $4.7 million, or $0.16 per diluted share, in the first quarter of fiscal 2024.
  • Non-GAAP net income was $2.2 million, or $0.07 per diluted share, compared to $5.2 million, or $0.18 per diluted share, in the same period last year.
  • The company's bookings for the quarter were $16.8 million, and backlog stood at $16.6 million as of August 30, 2024.
  • Aehr's cash, cash equivalents, and restricted cash totaled $40.8 million, down from $49.3 million at the end of the previous quarter, primarily due to the $10.6 million acquisition of Incal Technology, Inc.
  • The company is reaffirming its full-year revenue guidance of at least $70 million and net profit before taxes of at least 10% of revenue.

Sentiment

Score: 5

Explanation: The document presents mixed results with a significant decrease in revenue and profit compared to the previous year, but the company is reaffirming its full-year guidance and highlighting positive developments in new markets. The sentiment is neutral to slightly positive due to the future outlook.

Positives

  • Aehr finished the first quarter with revenue and non-GAAP net income ahead of consensus estimates.
  • The company is seeing stabilization and positive discussions within the silicon carbide power semiconductor market.
  • There is strong demand for their FOX WaferPak full wafer Contactors for silicon carbide.
  • Aehr is making progress with new silicon carbide device and module suppliers.
  • The company is in negotiations with its first gallium nitride (GaN) semiconductor customer for volume production.
  • An AI accelerator company is evaluating Aehr's FOX solution for wafer level burn-in.
  • The acquisition of Incal Technology, Inc. has been completed and is progressing well.
  • Aehr received first volume production orders for Incal's new Sonoma solution.
  • A key customer in the hard disk drive space is forecasting a production ramp-up starting this fiscal year.
  • The company is reaffirming its financial guidance for revenue growth and profitability for the year.

Negatives

  • Net revenue decreased to $13.1 million from $20.6 million in the same quarter of the previous year.
  • GAAP net income decreased to $0.7 million from $4.7 million year-over-year.
  • Non-GAAP net income decreased to $2.2 million from $5.2 million year-over-year.
  • Total cash, cash equivalents and restricted cash decreased to $40.8 million from $49.3 million at the end of the previous quarter.

Risks

  • The company's financial results for the first quarter of fiscal 2025 show a significant decrease in revenue and net income compared to the same period last year.
  • The decrease in cash, cash equivalents, and restricted cash could impact the company's ability to invest in future growth.
  • The company's reliance on the silicon carbide market could be a risk if that market does not grow as expected.
  • The integration of Incal Technology, Inc. could present challenges.
  • The company's ability to secure new customers and orders in emerging markets is not guaranteed.

Future Outlook

Aehr is reaffirming its full-year revenue guidance of at least $70 million and net profit before taxes of at least 10% of revenue for the fiscal year ending May 30, 2025. The company anticipates growth in silicon carbide, gallium nitride, and AI markets.

Management Comments

  • Gayn Erickson, President and CEO of Aehr Test Systems, stated that they finished the first quarter with revenue and non-GAAP net income ahead of consensus estimates and are off to a good start to their fiscal year.
  • Management believes silicon carbide wafer level burn-in test systems and full wafer contactors are poised to be key contributors to revenue again this year.
  • Management is forecasting material bookings and revenue contributions from several other markets this fiscal year.
  • Management is highly optimistic about their silicon carbide business and expects it to gain momentum over the next few quarters.
  • Management is confident that they will add several new silicon carbide customers this year.
  • Management believes GaN is a significant up and coming technology for power semiconductors.
  • Management anticipates that an AI accelerator company will adopt their high-power FOX-XP systems for production of their next-generation AI processors.
  • Management is very optimistic about the year ahead and is reaffirming their financial guidance for revenue growth and profitability for the year.

Industry Context

The announcement highlights Aehr's focus on the growing markets for silicon carbide, gallium nitride, and AI semiconductors, aligning with industry trends towards more efficient and powerful devices. The acquisition of Incal Technology positions Aehr to capitalize on the increasing demand for testing solutions in the AI sector.

Comparison to Industry Standards

  • Aehr's revenue decline in Q1 contrasts with some semiconductor equipment companies that have shown growth, such as Applied Materials which reported a 6% increase in revenue in their most recent quarter.
  • The company's focus on silicon carbide aligns with the industry trend, with companies like Wolfspeed and STMicroelectronics investing heavily in this area.
  • Aehr's move into the AI testing market with the Incal acquisition is similar to other companies like Teradyne that are expanding their offerings to address the growing demand for AI chip testing.
  • The company's gross profit margin of 53.9% is within the range of other semiconductor equipment companies, but lower than some high-margin players like ASML.
  • Aehr's reaffirmation of full-year guidance is a positive sign, but the company will need to show significant improvement in the coming quarters to meet these targets.

Stakeholder Impact

  • Shareholders may be concerned about the decrease in revenue and net income, but reassured by the reaffirmed full-year guidance.
  • Employees may be impacted by the integration of Incal Technology, Inc. and the consolidation of personnel and manufacturing.
  • Customers may benefit from the expanded product offerings and solutions in the silicon carbide, gallium nitride, and AI markets.
  • Suppliers may see increased demand for components used in Aehr's products.
  • Creditors may be impacted by the company's financial performance and cash position.

Next Steps

  • Aehr will continue to integrate Incal Technology, Inc. into its operations.
  • The company will focus on securing new customers and orders in the silicon carbide, gallium nitride, and AI markets.
  • Aehr will continue to evaluate its FOX solution with an AI accelerator company.
  • The company will work to meet its full-year revenue and profitability guidance.

Key Dates

DateDescription
August 30, 2024End of the first quarter of fiscal year 2025.
October 10, 2024Date of the press release announcing the first quarter fiscal 2025 financial results.
May 30, 2025End of the fiscal year 2025.

Keywords

semiconductor test, burn-in equipment, silicon carbide, wafer level, gallium nitride, AI processors, FOX WaferPak, Incal Technology, financial results, revenue, net income, bookings, backlog

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.